How to combine dual aims of reducing population growth and a rights-based non-coercive approach
Response to ‘Family Planning, population growth, and the environment’ by Jeffrey T. Jensen and Mitchell D. Creinin: Contraception 2020;101:145-147. (Source: Contraception)
Source: Contraception - March 26, 2020 Category: OBGYN Authors: Chris Smith Tags: Letter to the Editor Source Type: research

Editorial Board
(Source: Contraception)
Source: Contraception - March 19, 2020 Category: OBGYN Source Type: research

Copyright info/Contents
(Source: Contraception)
Source: Contraception - March 19, 2020 Category: OBGYN Source Type: research

Ultrasound Location of Intrauterine Devices Placed at Cesarean Section over the First Year Postpartum
The primary objective was to measure IUD-fundus and IUD-myometrium distances by ultrasound of IUDs placed during cesarean section over the first year of use. The secondary objective was to determine if these distances are associated with risk of expulsion or removal for side effects. (Source: Contraception)
Source: Contraception - March 19, 2020 Category: OBGYN Authors: Julie Gonzalez, Samantha Stimmel, Rima Rana Do, Ms. Alexandra I. Diggs, Ms. Stephanie Pan, Ms. Jessica Overbey, Albert George Thomas, Britt Lunde Tags: Original Research Article Source Type: research

Pregnancy intentions and contraceptive uptake after miscarriage
To identify factors associated with contraceptive uptake among participants in a miscarriage management clinical trial. (Source: Contraception)
Source: Contraception - March 18, 2020 Category: OBGYN Authors: Andrea H. Roe, Arden McAllister, Mary D. Sammel, Courtney A. Schreiber Tags: Original Research Article Source Type: research

Contextualizing Medicaid reimbursement rates for abortion procedures
This study examines differences between Medicaid and Medicare reimbursements for abortion and miscarriage management procedures under a fee-for-service (FFS) model. (Source: Contraception)
Source: Contraception - March 18, 2020 Category: OBGYN Authors: Yves-Yvette Young, Terri-Ann Thompson, David C. Cohen, Kelly Blanchard Tags: Original Research Article Source Type: research

Assessment of Contraceptive Use in Puerto Rico during the 2016 Zika Virus Outbreak
The objectives of this analysis were to 1) estimate prevalence of contraceptive use among women at risk for unintended pregnancy and 2) identify correlates of contraceptive use among women with ongoing or potential need for contraceptive services in Puerto Rico during the 2016 Zika virus (ZIKV) outbreak.Study DesignWe conducted a cell-phone survey July –November, 2016. Women aged 18–49 years living in Puerto Rico were eligible. We completed 3,059 interviews; the overall response rate was 69.2%. After weighting, the data provide population-based estimates. (Source: Contraception)
Source: Contraception - March 17, 2020 Category: OBGYN Authors: Sascha R Ellington, Ruby Serrano Rodriguez, Howard Goldberg, Jeanne Bertolli, Regina Simeone, Amilcar Soto Mercado, Karen Pazol, Denise J. Jamieson, Margaret A. Honein, Andrea Swartzendruber, Toni Miles, Jose Cordero, Carrie Shapiro-Mendoza Tags: Original Research Article Source Type: research

Mifepristone pretreatment Followed by Misoprostol 200mcg Buccal for the Medical Management of Intrauterine Fetal Death at 14-28 Weeks: A Randomized, Placebo-controlled, Double Blind Trial
To evaluate whether fetal and placental expulsion is more likely within 48 hours if women receive mifepristone pre-treatment versus placebo pre-treatment followed by misoprostol 200mcg buccally for treatment of fetal death at 14 weeks 0 days to 28 weeks and 6 days gestation.Study Design: We randomized 176 women with a confirmed fetal death between 14 weeks and 0 days to 28 weeks and 6 days to mifepristone 200 mg or placebo; 24 hours later all participants received misoprostol 200 mcg buccally every 3 hours for up to 16 doses or 48 hours. (Source: Contraception)
Source: Contraception - March 2, 2020 Category: OBGYN Authors: Hillary Bracken, Nguyen thi Nhu Ngoc, Do Quan Ha, Norberto Reyes Paredes, Vu Ba Quyet, Nguyen Thi Huyen Linh, Marco Antonio Ortiz, Manuel Bousieguez, Beverly Winikoff Tags: Original Research Article Source Type: research

The concentration of fetal red blood cells in first-trimester pregnant women undergoing uterine aspiration is below the calculated threshold for Rh sensitization
To calculate the minimum fetal red blood cell concentration required to cause maternal Rh sensitization; validate the use of a flow cytometry protocol below that concentration; preliminarily assess the concentrations of fetal red blood cells in pregnant women before and after uterine aspiration.Study Design:Using pre-existing literature, we calculated the lowest concentration of fetal red blood cells found to cause sensitization within adult female circulation. We validated a two-color flow cytometry protocol using fluorescently labeled antibodies to Hemoglobin F (expressed by fetal red blood cells and adult F cells) and C...
Source: Contraception - March 2, 2020 Category: OBGYN Authors: Sarah Horvath, Patricia Tsao, Zhen-Yu Huang, Ling Zhao, Yangzhu Du, Mary D. Sammel, Eline T. Luning Prak, Courtney A. Schreiber Tags: Original Research Article Source Type: research

Editorial Board
(Source: Contraception)
Source: Contraception - February 28, 2020 Category: OBGYN Source Type: research

Copyright info/Contents
(Source: Contraception)
Source: Contraception - February 28, 2020 Category: OBGYN Source Type: research

A Simulated Patient Study to Assess Referrals to Abortion Care by Student Health Centers in Pennsylvania
To determine college health centers ’ referral patterns for students seeking induced abortion.Study DesignWe conducted a cross-sectional simulated patient study at 4-year colleges in Pennsylvania between June 2017 and May 2018. A researcher posing as a student seeking abortion referral contacted student health centers twice during t he course of the study using a structured script, once as a minor (under 18 years), and once as an adult. The primary outcome was “direct referral”, defined as a referral to an abortion provider. (Source: Contraception)
Source: Contraception - February 27, 2020 Category: OBGYN Authors: Priyanka Anand, Arden McAllister, Tegan Hunter, Courtney Schreiber, Nathanael Koelper, Sarita Sonalkar Tags: Original Research Article Source Type: research

The effects of CenteringPregnancy group prenatal care on postpartum visit attendance and contraception use
We examined whether Medicaid-enrolled women in CenteringPregnancy group prenatal care had higher rates of 1) postpartum visit attendance and 2) postpartum uptake of contraceptives, compared to women in individual prenatal care.Study designWe linked birth certificates and Medicaid claims for women receiving group prenatal care in 18 healthcare practices and applied preferential-within cluster propensity score methods to identify a comparison group, accounting for the nested data structure by practice. (Source: Contraception)
Source: Contraception - February 27, 2020 Category: OBGYN Authors: Emily Heberlein, Jessica Smith, Carla Willis, Wendasha Hall, Sarah Covington-Kolb, Amy Crockett Tags: Original Research Article Source Type: research

Contraceptive use among women with cystic fibrosis: A pilot study linking reproductive health questions to the Cystic Fibrosis Foundation National Patient Registry
To examine contraceptive use, pregnancy intention and the association of hormonal contraceptive type with adverse health outcomes among women with cystic fibrosis (CF). (Source: Contraception)
Source: Contraception - February 25, 2020 Category: OBGYN Authors: Emily M. Godfrey, Sheila Mody, Malaika R. Schwartz, Sonya L. Heltshe, Jennifer L. Taylor-Cousar, Raksha Jain, Sandra Sufian, Tatiana Josephy, Moira L. Aitken Tags: Original Research Article Source Type: research

Exploring Crowdfunding Campaigns for Abortion Services
To examine the use of crowdfunding to pay for abortion services for individuals in the United States.Study Design: Cross-sectional analysis of data abstracted from publicly available campaigns for abortion services on four major crowdfunding sites. (Source: Contraception)
Source: Contraception - February 24, 2020 Category: OBGYN Authors: Michael T. Solotke, Nicole Brussel Faria, Hasna Karim, Shireen Roy, Joseph S. Ross, Julia Cron Tags: Brief Research Article Source Type: research

Multicenter, open-label trial to assess the safety and tolerability of drospirenone 4.0  mg over 6 cycles in female adolescents, with a 7-cycle extension phase
To assess the safety, tolerability and bleeding patterns of drospirenone 4.0  mg. (Source: Contraception)
Source: Contraception - February 20, 2020 Category: OBGYN Authors: Dan Apter, Enrico Colli, Kristina Gemzell-Danielsson, Klaus Peters Tags: Original Research Article Source Type: research

Multicenter, Open-Label Trial to Assess the Safety and Tolerability of Drospirenone 4.0 mg Over 6 Cycles in Female Adolescents, With a 7-Cycle Extension Phase
To assess the safety, tolerability and bleeding patterns of drospirenone 4.0 mg.Study DesignA multicenter, open-label, safety trial in sexually-active adolescents aged 12-17 years for six 28-day treatment cycles (Core Phase) and an optional 7-13 cycle extension with administration of drospirenone 4.0 mg in a regimen of 24 active/4 placebo tablets. (Source: Contraception)
Source: Contraception - February 20, 2020 Category: OBGYN Authors: Dan Apter, Enrico Colli, Kristina Gemzell Danielsson, Klaus Peters Tags: Original Research Article Source Type: research

“$231 … to pull a string!!!” American IUD users’ reasons for IUD self-removal: an analysis of internet forums
This study describes the reasons for IUD self-removal as documented in internet forums by IUD users discussing self-removal. (Source: Contraception)
Source: Contraception - February 20, 2020 Category: OBGYN Authors: Jennifer R. Amico, Samantha Stimmel, Shawna Hudson, Marji Gold Tags: Original Research Article Source Type: research

Postplacental intra-abdominal placement of levonorgestrel 52  mg intrauterine system: A case report
This case of an intra-abdominal levonorgestrel 52  mg intrauterine system found three weeks after manual postplacental placement demonstrates the importance of proper insertion technique and ascertainment of fundal placement. Ultrasound guidance can be considered if fundal placement is uncertain. Short interval follow up should be recommended to confirm proper placement. (Source: Contraception)
Source: Contraception - February 18, 2020 Category: OBGYN Authors: Sarah F. Peterson, Andrea Henkel, Amitha Ganti, Paul D. Blumenthal Tags: Case Report Source Type: research

Postplacental intra-abdominal placement of levonorgestrel 52mg intrauterine system: a case report
This case of an intra-abdominal levonorgestrel 52mg intrauterine system found three weeks after manual postplacental placement demonstrates the importance of proper insertion technique and ascertainment of fundal placement. Ultrasound guidance can be considered if fundal placement is uncertain. Short interval follow up should be recommended to confirm proper placement. (Source: Contraception)
Source: Contraception - February 18, 2020 Category: OBGYN Authors: Sarah F. Peterson, Andrea Henkel, Amitha Ganti, Paul D. Blumenthal Tags: Case Report Source Type: research

Predictors of choosing long-acting reversible contraceptive methods when provided free-of-charge – a prospective cohort study in finland
To identify factors associated with choosing long-acting reversible contraception (LARC) (intrauterine device or contraceptive implant), when provided free-of-charge.Study Design: This register-based cohort study comprises all women living in the city of Vantaa in the Helsinki metropolitan area during 2013 –2014, with information on LARC initiations retrieved from electronic health records. Since January 2013, women in Vantaa can receive their first LARC method free-of-charge at public contraceptive clinics. (Source: Contraception)
Source: Contraception - February 13, 2020 Category: OBGYN Authors: Frida Gyllenberg, Tuire Saloranta, Anna But, Mika Gissler, Oskari Heikinheimo Tags: Original Research Article Source Type: research

Risk of Vasectomy Failure by Ligation and Excision with Fascial Interposition: A Prospective Descriptive Study
To evaluate the occlusive failure risk of ligation and excision with fascial interposition vasectomy technique. There are doubts about the effectiveness of this technique largely used in Asia and Latin America. (Source: Contraception)
Source: Contraception - February 13, 2020 Category: OBGYN Authors: Silvia Juliana Miranda Claro, Jonathan Vargas Laverde, Elsa Mari ño Samper, Milcíades Ibáñez Pinilla, Diana Soraya Torres Quiroz, Michel Labrecque Tags: Original Research Article Source Type: research

Abortion for fetal indications: Timing of Prenatal Diagnosis and Abortion for Structural and Genetic Abnormalities
To compare diagnoses in patients undergoing abortion for fetal indications at 15-0/7 to 21-6/7vs. ≥22-0/7 weeks’ gestation. (Source: Contraception)
Source: Contraception - February 13, 2020 Category: OBGYN Authors: Caroline F. Friedman, Stephen T. Chasen Tags: Original Research Article Source Type: research

Response to requests for contraception in one direct-to-consumer telemedicine service
To describe real-world care seeking and contraception provision in one direct to consumer telemedicine platform. (Source: Contraception)
Source: Contraception - February 11, 2020 Category: OBGYN Authors: Kathryn A. Martinez, Radhika Rastogi, Laura Lipold, Michael B. Rothberg Tags: Brief Research Article Source Type: research

Family planning, population growth, and the environment
As we enter a new decade and the 50th anniversary year for Contraception, earth ’s human population is nearly 7.8 billion. When Dan Mishell started our journal in 1970, earth’s population had not yet reached 4 billion. By this metric, one might conclude that our efforts at family planning have failed. More optimistically, we look at the considerable diversity of modern cont raceptive methods, and the impact they have made in improving women’s lives and at reducing the risk of unintended pregnancy. (Source: Contraception)
Source: Contraception - February 11, 2020 Category: OBGYN Authors: Jeffrey T. Jensen, Mitchell D. Creinin Tags: Commentary Source Type: research

A cross-sectional analysis of mifepristone, misoprostol, and combination mifepristone-misoprostol package inserts obtained in 20 countries
To evaluate the characteristics, clinical information, and storage instructions contained in package inserts from medical abortion commodities collected in low- and middle-income countries. (Source: Contraception)
Source: Contraception - February 5, 2020 Category: OBGYN Authors: Laura J. Frye, Catherine Kilfedder, Jennifer Blum, Beverly Winikoff Tags: Original Research Article Source Type: research

Dilation and Evacuation after Preterm Premature Rupture of Membranes with Abdominal Cerclage in situ
We present a patient at 17 weeks 3 day gestation with preterm premature rupture of membranes, chorioamnionitis with an abdominal cerclage in situ. She desired uterine evacuation via dilation and evacuation. This case report reviews the clinical considerations for uterine evacuation in the second trimester in patients with an abdominal cerclage in situ and discusses options for cervical preparation prior to dilation and evacuation for this unique patient population. (Source: Contraception)
Source: Contraception - February 5, 2020 Category: OBGYN Authors: Alix E Perry, Tania Basu Serna Tags: Case Report Source Type: research

When Patients Change Their Minds After Starting an Abortion: Guidance from the National Abortion Federation ’s Clinical Policies Committee
The number of people who wish to stop an abortion once it has started is low. There is little evidence-based guidance for clinicians about how to help those few patients who may want to stop an abortion procedure once it has started. This National Abortion Federation Clinical Policies Committee guidance discusses certainty around abortion decision making, the frequency with which patients wish to interrupt an abortion procedure once it has started, pregnancy outcomes, and clinical guidance for practitioners should this unlikely event occur. (Source: Contraception)
Source: Contraception - February 5, 2020 Category: OBGYN Authors: Alice Mark, Daniel Grossman, Angel M. Foster, Sarah W. Prager, Beverly Winikoff Tags: Commentary Source Type: research

Minimally-invasive fully ultrasound-guided removal of nonpalpable single-rod contraceptive implant: case report and technical description
A 38 year-old patient had a nonpalpable subfascial single-rod contraceptive implant close to major neurovascular structures. We removed the implant through a 3 mm incision using local anesthesia, hydrodissection and a grasping micro-forceps under continuous real-time ultrasound guidance. (Source: Contraception)
Source: Contraception - February 4, 2020 Category: OBGYN Authors: Thibaut Jacques, Simon Henry, Geraldine Giraudet, Xavier Demondion, Anne Cotten Tags: Case Report Source Type: research

Birth Control Connect: a randomized trial of an online group to disseminate contraceptive information
We sought to test whether participation in an online group including IUD users influenced IUD-related knowledge, attitudes, and behavior among IUD non-users, as a proof-of-concept evaluation of information dissemination for less commonly used or novel contraceptives.Study Design: We conducted a blinded, randomized controlled trial on the effect of online communication with IUD users within an online program called Birth Control Connect. Participants were women age 18-45 living in the United States who had never used an IUD. (Source: Contraception)
Source: Contraception - February 4, 2020 Category: OBGYN Authors: Christine Dehlendorf, Edith Fox, Anjana E. Sharma, Jingwen Zhang, Sijia Yang, Damon Centola Tags: Original Research Article Source Type: research

Editorial Board
(Source: Contraception)
Source: Contraception - February 1, 2020 Category: OBGYN Source Type: research

Copyright info/Contents
(Source: Contraception)
Source: Contraception - February 1, 2020 Category: OBGYN Source Type: research

The 6th International IUD Symposium
Worldwide prevalence of IUD use is 13% (approximately 250 million women), making this technology the most widely used form of reversible fertility control [1]. Use patterns vary considerably by country/region: Sub-Saharan Africa (1%), India (1.5%), Latin America/Caribbean (6%), Asia (excluding China, 6%), United States (8.6%) [2], Europe (11%). In China, 41% of women use IUDs (approximately 141 million users); this high prevalence in the world ’s most populated country drives global statistics. Excluding China, global prevalence of IUD use is approximately 6%. (Source: Contraception)
Source: Contraception - February 1, 2020 Category: OBGYN Authors: David Hubacher, Jim Sailer, Carolyn L. Westhoff, the IUD Symposium Organizing Committee Tags: Editorial Source Type: research

A non-inferiority study of outpatient mifepristone-misoprostol medical abortion at 64 –70 days and 71–77 days of gestation
This open-label non-inferiority study assessed efficacy of a common outpatient medical abortion regimen among people with pregnancies 64 –70 days and 71–77 days of gestation. (Source: Contraception)
Source: Contraception - January 31, 2020 Category: OBGYN Authors: Ilana G. Dzuba, Erica Chong, Curtiss Hannum, E. Steve Lichtenberg, Elba Margarita Lugo Hern ández, Nguyen thi Nhu Ngoc, Ashlesha Patel, Gulnara Rzayeva, Patricio Sanhueza Smith, George Tsertsvadze, Beverly Winikoff Tags: Original Research Article Source Type: research

Sensitivity and Specificity of Placental Proteins for Gestational Age Screening: An Exploratory Study
To examine the possibility that serum or urine concentrations of pregnancy-associated plasma protein A (PAPP-A), a disintegrin and metalloproteinase 12 (ADAM-12), placental growth factor (PlGF), human placental lactogen (HPL), glypican-3, pregnancy specific beta-1-glycoprotein 1 (PSG-1) or prolactin could predict gestational age (GA)>70 days, the currently recommended limit for medical abortion in the United States. (Source: Contraception)
Source: Contraception - January 31, 2020 Category: OBGYN Authors: Elizabeth G. Raymond, Laura J. Frye, Mark A. Weaver, Joel P. Lebed, Xiangdong Ren, Elizabeth Steider, Beverly Winikoff, Kurt T. Barnhart Tags: Original Research Article Source Type: research

A non-inferiority study of outpatient mifepristone-misoprostol medical abortion at 64-70 days and 71-77 days of gestation
This open-label non-inferiority study assessed efficacy of a common outpatient medical abortion regimen among people with pregnancies 64-70 days and 71-77 days of gestation.Study DesignWe defined non-inferiority by a 6% margin of method success. People with intrauterine pregnancies 64-77 days ’ gestational age by abdominal ultrasound seeking medical abortion at one of eight clinics and met eligibility criteria were offered participation. Consenting participants took mifepristone 200 mg followed 24-48 hours later by misoprostol 800 mcg buccally, and returned after one week for provider evaluation and abdominal ultraso...
Source: Contraception - January 31, 2020 Category: OBGYN Authors: Ilana G. Dzuba, Erica Chong, Curtiss Hannum, E. Steve Lichtenberg, Elba Margarita Lugo Hern ández, Nguyen thi Nhu Ngoc, Ashlesha Patel, Gulnara Rzayeva, Patricio Sanhueza Smith, George Tsertsvadze, Beverly Winikoff Tags: Original Research Article Source Type: research

Perceptions of Long-Acting Reversible Contraception among Women Receiving Medication for Opioid Use Disorder in Vermont
To evaluate perceptions of long-acting reversible contraceptives (LARC) among women receiving medication for opioid use disorder. (Source: Contraception)
Source: Contraception - January 31, 2020 Category: OBGYN Authors: Catalina N. Rey, Gary J. Badger, Heidi S. Melbostad, Deborah Wachtel, Stacey C. Sigmon, Lauren K. MacAfee, Anne K. Dougherty, Sarah H. Heil Tags: Original Research Article Source Type: research

Society of Family Planning clinical recommendations: Cervical preparation for dilation and evacuation at 20 –24 weeks’ gestation
Although only 1.3% of abortions in the United States are between 20 and 24  weeks’ gestation, these procedures are associated with elevated risks of morbidity and mortality. Adequate cervical preparation before dilation and evacuation (D&E) at 20 –24 weeks’ gestation reduces procedural risk. For this gestational range, at least one day of cervical preparation with osmotic dilators is recommended before D&E. The use of overnight osmotic dilators alone is sufficient for most D&Es at 20 –24 weeks’ gestation. (Source: Contraception)
Source: Contraception - January 30, 2020 Category: OBGYN Authors: Justin T. Diedrich, Eleanor A. Drey, Sara J. Newmann Tags: Review Article Source Type: research

Cervical preparation for dilation and evacuation at 20 –24 weeks’ gestation
Although only 1.3% of abortions in the United States are between 20 –24 weeks’ gestation, these procedures are associated with elevated risks of morbidity and mortality. Adequate cervical preparation before dilation and evacuation (D&E) at 20 –24 weeks' gestation reduces procedural risk. For this gestational range, at least one day of cervical preparation with osmotic dilators is recommended before D&E. The use of overnight osmotic dilators alone is sufficient for most D&Es at 20-24 weeks ’ gestation. (Source: Contraception)
Source: Contraception - January 30, 2020 Category: OBGYN Authors: Justin T. Diedrich, Eleanor A. Drey, Sara J. Newmann Tags: Review Article Source Type: research

The benefits and limitations of donating new contraceptive technology: The case of the International Contraceptive Access (ICA) Foundation and the LNG IUS Program in Brazil
The objective of the Foundation was to provide public service-delivery organizations with the levonorgestrel 52 mg intrauterine system (LNG IUS) on a not-for-profit basis to serve the reproductive needs of women in resource-poor settings in developing countries. (Source: Contraception)
Source: Contraception - January 30, 2020 Category: OBGYN Authors: Laura Miranda, John Townsend, Anibal Fa úndes, Luis Bahamondes Tags: Commentary Source Type: research

Safety of deep sedation without intubation during surgical abortion in the independent clinic setting
To establish the safety of deep sedation without intubation delivered by a certified registered nurse anesthetist (CRNA) in an independent outpatient abortion setting.Study DesignWe performed a review of clinic Quality and Patient Safety Reports, a daily-maintained report of complications at time of all dilation and curettage (D&C) and dilation and evacuation (D&E) procedures performed at an independently operated, urban, high-volume abortion clinic between March 2013 to August 2017. The clinic provided procedures through 23 weeks 6 days gestation to women at low risk for medical or surgical complications, referrin...
Source: Contraception - January 29, 2020 Category: OBGYN Authors: Renita Kim, Andrea Pelletier, Brian Donnenfeld, Laurent Delli-Bovi, Deborah Bartz Tags: Original Research Article Source Type: research

Contraceptive implant uptake in Kenya versus South Africa: lessons for new implantable technologies
Contraceptive implant use has been rapidly increasing across much of sub-Saharan Africa (SSA) over the past decade; however, this uptake has not been uniform. In this commentary we explore two country-level case studies with differing experiences with the contraceptive implant: Kenya and South Africa. The implant has been available in Kenya for over 25 years, and prevalence among married women is the highest in the world at 22.8%. While the implant has been available for only five years in South Africa, implant insertions have been declining since an introductory surge. (Source: Contraception)
Source: Contraception - January 23, 2020 Category: OBGYN Authors: Emily A. Krogstad, Ojwang K. Odhiambo, Mark Ayallo, Veronique C. Bailey, Helen Rees, Ariane van der Straten Tags: Commentary Source Type: research

Computer-Assisted Motivational Interviewing for Contraceptive Use in Women Leaving Prison: A Randomized Controlled Trial
In this study, we assessed the efficacy of motivational interviewing as an individualized intervention to increase the initiation of contraceptive methods while incarcerated and continuation after release in female inmates who wanted to avoid pregnancy for at least one year after release. (Source: Contraception)
Source: Contraception - January 23, 2020 Category: OBGYN Authors: Brousseau E. Christine, G. Clarke Jennifer, Dumont Dora, A.R. Stein Lynda, Roberts Mary, J. van den Berg Jacob Tags: Original Research Article Source Type: research

Does Distance Decrease Healthcare Options for Pregnant, Incarcerated People? Mapping the Distance between Abortion Providers and Prisons
Pregnant, incarcerated people retain the constitutional right to abortion, but evidence suggests that many cannot access abortion services. State and federal prisons are often located in remote areas and there is a known shortage of abortion providers across the U.S., particularly in remote areas. The goal of this study was to determine the proximity of state and federal prisons to the nearest abortion clinic. (Source: Contraception)
Source: Contraception - January 23, 2020 Category: OBGYN Authors: Julia Gips, Kevin J. Psoter, Carolyn Sufrin Tags: Original Research Article Source Type: research

An exploratory study of depot-medroxyprogesterone acetate and bone mineral density in adolescent and young adult women with cerebral palsy
To explore whether use of depot-medroxyprogesterone acetate (DMPA) in adolescent and young adult females with cerebral palsy is associated with lower bone mineral density (BMD). (Source: Contraception)
Source: Contraception - January 11, 2020 Category: OBGYN Authors: R. Claire Roden, Garey Noritz, Erin R. McKnight, Andrea E. Bonny Tags: Brief Research Article Source Type: research

Primary care patients ’ preferences for reproductive health service needs assessment and service availability in New York Federally Qualified Health Centers
Expanding reproductive health services in primary care could increase access to preconception and contraceptive services. We assessed patients ’ preferences around wording, frequency and staffing for reproductive health service needs assessment and availability of a range of reproductive health services in primary care. (Source: Contraception)
Source: Contraception - January 11, 2020 Category: OBGYN Authors: Heidi E. Jones, Cynthia Calixte, Meredith Manze, Michele Perlman, Susan Rubin, Lynn Roberts, Diana Romero Tags: Original Research Article Source Type: research

An Exploratory Study of Depot-Medroxyprogesterone Acetate and Bone Mineral Density in Adolescents and Young Adult Women with Cerebral Palsy
To explore whether use of depot-medroxyprogesterone acetate (DMPA) in adolescent and young adult females with cerebral palsy is associated with lower bone mineral density (BMD). (Source: Contraception)
Source: Contraception - January 11, 2020 Category: OBGYN Authors: R. Claire Roden, Garey Noritz, Erin.R. McKnight, Andrea E. Bonny Tags: Brief Research Article Source Type: research

One Key Question ® and the Desire to Avoid Pregnancy Scale: A Comparison of Two Approaches to Asking About Pregnancy Preferences
To facilitate assessment of patients ’ pregnancy preferences, we compared responses to One Key Question® with the validated Desire to Avoid Pregnancy (DAP) scale and assessed their relationships to patient-reported reproductive health behaviors. (Source: Contraception)
Source: Contraception - January 11, 2020 Category: OBGYN Authors: Debra Stulberg, Avisek Datta, Emily White VanGompel, Kellie Schueler, Corinne H. Rocca Tags: Original Research Article Source Type: research

The Influence of Health Care Utilization on the Association between Hormonal Contraception Initiation and Subsequent Depression Diagnosis and Antidepressant Use
Assess the influence of healthcare utilization on previously reported associations between contraception initiation, diagnosis of depression, and dispensing of antidepressant medications. (Source: Contraception)
Source: Contraception - January 11, 2020 Category: OBGYN Authors: Sarah Ditch, Timothy A. Roberts, Shana Hansen Tags: Original Research Article Source Type: research

Comparison of a transdermal contraceptive patch with a newly sourced adhesive component versus EVRA patch: A double-blind, randomized, bioequivalence and adhesion study in healthy women
To evaluate the bioequivalence of norelgestromin and ethinyl estradiol (NGMN-EE) and adhesion of a transdermal contraceptive patch containing a newly sourced adhesive component (test) compared with the marketed (reference) patch. (Source: Contraception)
Source: Contraception - January 11, 2020 Category: OBGYN Authors: Dolly A. Parasrampuria, Subusola Vaughan, Jay Ariyawansa, Aline Swinnen, Jaya Natarajan, Freya Rasschaert, Joseph Massarella, Sergio Fonseca Tags: Original Research Article Source Type: research